Expression vector of human CDCA7 wild-type.
Alternative name | p3XFLAG-CMV10-CDCA7 WT |
---|---|
Clone info. | Expression vector of human cell division cycle associated 7 (CDCA7) wild-type, tagged with 3 x FLAG at N-terminus. Structure, see Fig. S1 of Unoki, M. et al., J. Clin. Invest., 129 (1): 78-92, 2019. |
Comment | Expression was confirmed by the depositor with western blottingand RT-PCR. |
Vector backbone | p3xFLAG-CMV-10 (plasmid) |
Size of vector backbone | 6.3 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cells). |
Gene/insert name | human CDCA7 cDNA |
Depositor|Developer | Unoki, Motoko | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR (Unoki, M et al. J. Clin. Invest. 129 (1), 78-92, 2019) and an acknowledgment to the DEPOSITOR are requested. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献 (Unoki, M et al. J. Clin. Invest. 129 (1), 78-92, 2019) を引用し、謝辞の表明を必要とする。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB17374 | p3XFLAG-CDCA7 WT | DNA solution |
Materials & Methods section:
The p3XFLAG-CDCA7 WT was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB17374). |
Reference section:
Unoki, M., Funabiki, H., Velasco, G., Francastel, C., Sasaki, H., CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome. J. Clin. Invest. 129 (1): 78-92 (2019). PMID 30307408. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB17374_A9Fhp1-1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV-Forward () Region: CMV pro, 3xFLAG, insert 5' Sequence file: RDB17374_A9Fha.seq |
---|
>D06399A1_A9Fh_3_CMV_Forward_A01_01_ABI08.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNNNGCN NNGGGCGGTA GGCGTGTACG GTGGGAGGTC 61 TATATAAGCA GAGCTCGTTT AGTGAACCGT CAGAATTAAC CATGGACTAC AAAGACCATG 121 ACGGTGATTA TAAAGATCAT GACATCGATT ACAAGGATGA CGATGACAAG CTTGCGGCCG 181 CGAATTCATC GATAGATCTG ATATCGGTAC CAATGGACGC TCGCCGCGTG CCGCAGAAAG 241 ATCTCAGAGT AAAGAAGAAC TTAAAGAAAT TCAGATATGT GAAGTTGATT TCCATGGAAA 301 CCTCGTCATC CTCTGATGAC AGTTGTGACA GCTTTGCTTC TGATAATTTT GCAAACACGA 361 GGCTGCAGTC AGTTCGGGAA GGCTGTAGGA CCCGCAGCCA GTGCAGGCAC TCTGGACCTC 421 TCAGGGTGGC GATGAAGTTT CCAGCGCGGA GTACCAGGGG AGCAACCAAC AAAAAAGCAG 481 AGTCCCGCCA GCCCTCAGAG AATTCTGTGA CTGATTCCAA CTCCGATTCA GAAGATGAAA 541 GTGGAATGAA TTTTTTGGAG AAAAGGGCTT TAAATATAAA GCAAAACAAA GCAATGCTTG 601 CAAAACTCAT GTCTGAATTA GAAAGCTTCC CTGGCTCGTT CCGTGGAAGA CATCCCCTCC 661 CAGGCTCCGA CTCACAATCA AGGAGACCGC GAAGGCGTAC ATTCCCGGGT GTTGCTTCCA 721 NGAGAAACCC TGAACGGAGA GCTCGTCCTC TTACCANGTC AAGGTCNCGG ATCCTCGGGT 781 CCNTTGACGC TCTACCCNTG GAGGANGANG ANGAAGAGGA NAAGTACNTG TTGGTGAGAA 841 AGANGAAGAN NGTGGNTGGN TACNTGAATG AANATGACCT GNCCNNAAGC CNNCGCTCCA 901 NATCATCCGN NANNNNTTNN NNNTNTNNNT NNNNNNNNNN // |
Primer: hGHpolyA-R () Region: hGHp(A), insert 3' Sequence file: RDB17374_A9Fhb.seq |
>D06399A1_A9Fh_3_hGHpolyA-R_B01_04_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNAGGA NACCTAGTCN GACAAAATGA 61 TGCAACTTAA TTTTATTAGG ACAAGGCTGG TGGGCACTGG AGTGGCAACT TCCAGGGCCA 121 GGAGAGGCAC TGGGGAGGGG TCACAGGGAT GCCACCCGGG ATCCTCTAGA TTATGCTTGC 181 ATTTCAAATT CCTGTTTCAG GCTTTTCAAG TAGGCATGCA CATTCCCAAA GCCATGATAT 241 TTGGCTAAAT ACACAAGGAC CCCAGTCGCA CACCGTCCAT CTCGCTGCCG GCAGAAACTG 301 CAGTTGCAGA TTCCTCGACA AGGCGGGCAA TGCCAGTTCG GATCCAGCAG AGCATCCCTG 361 ACCTCTTCAC CATAACGGTT TCGAAGGCAG GGGCCACAGA ACTGGCCTCG AACGCCCCAG 421 CAGTCTGGGT TTCTGCAGTT TGTTTTGGTA TCAATAGTCT TCTGACGGCA TTGATGACAA 481 GTAGAGCCCA GTGAACGGTT ATATATCTTC TCTCGAGAAT TGCTGCAGAC GTTCTCCAAC 541 TCCTCCTCTG TAATTTCTTC CACTGGGCGA ATTATATGCG GAAGGGTCAC GGATGATCTG 601 GAGCGACGGC TTCTGGGCAG GTCATCTTCA TTCATGTAGC CNTCCACGGT CTTCCTCTTT 661 CTCACCAACA TGTACTTATC CTCTTCCTCC TCCTCCTCCA TGGGTAGAGC GTCAAGGGAC 721 CCGAGGATCC GGGACCTTGA CCTGGNAAGA GGACGAGCTC TCCGTTCAGG GTTTCTCCTG 781 NAAGCAACAC CCGGNNATGT ACGCCTTCNN GGNCTCNTNG ATTGNGAGTC GGANCCTNNN 841 ANGGGANGTC TTCCACGGAA CGANCCNGGG AANCTTTCTA ANTNNANANA TGANTTTTGN 901 NANCATNGCT TTGTTTTGCT TTANATTTAA AGCCCNTTTN NCCAAAAAAT NNATTNNNNT 961 TTNNTNTTCT GAATNNGANT TGGNATCNNN CACNNNNNNN NCNNANGNNT GNNGGNNNNN 1021 NGCNTTTTTT NNNNGNNNNN NNNCNNNNNN NNNN // |
Primer: SV40pro_F () Region: NeoR/KanR Sequence file: RDB17374_A9Fhc.seq |
>D06399A1_A9Fh_3_SV40pro_F_B01_02_ABI08.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNGNNNGANG NTTTTTTGGA GGANNTGATC 61 NGCTTGGGAN CTGATCAAGA GACAGGATGA GGATCGTTTC GCATGATTGA ACAAGATGGA 121 TTGCACGCAG GTTCTCCGGC CGCTTGGGTG GAGAGGCTAT TCGGCTATGA CTGGGCACAA 181 CAGACAATCG GCTGCTCTGA TGCCGCCGTG TTCCGGCTGT CAGCGCAGGG GCGCCCGGTT 241 CTTTTTGTCA AGACCGACCT GTCCGGTGCC CTGAATGAAC TGCAGGACGA GGCAGCGCGG 301 CTATCGTGGC TGGCCACGAC GGGCGTTCCT TGCGCAGCTG TGCTCGACGT TGTCACTGAA 361 GCGGGAAGGG ACTGGCTGCT ATTGGGCGAA GTGCCGGGGC AGGATCTCCT GTCATCTCAC 421 CTTGCTCCTG CCGAGAAAGT ATCCATCATG GCTGATGCAA TGCGGCGGCT GCATACGCTT 481 GATCCGGCTA CCTGCCCATT CGACCACCAA GCGAAACATC GCATCGAGCG AGCACGTACT 541 CGGATGGAAG CCGGTCTTGT CGATCAGGAT GATCTGGACG AAGAGCATCA GGGGCTCGCG 601 CCAGCCGAAC TGTTCGCCAG GCTCAAGGCG CGCATGCCCG ACGGCGAGGA TCTCGTCGTG 661 ACCCATGGCG ATGCCTGCTT GCCGAATATC ATGGTGGAAA ATGGCCGCTT TTCTGGATTC 721 NTCGACTGTG GNCGGCTGGG TGTGGCGGAN CNCTATCANG ACATAGCGTT GGCTACCCGN 781 GATATTGCTG AAGAGCTTGN CGGCGANNGG GCTGANCGCT TCCTCNTGCT TTACNNNATC 841 NNCGCTCCCN ANTCNNNNNG NATCNNCTTC TATCNNNTNC TTGANNANNN CNTCTGANCG 901 GGACTCTGGG GGNTCNAAAN TGACCGANNN NNCGACGNNN NNNNCNNNNN NTNNNNNNNN 961 TNNNANNNNN NNNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
original | Unoki, M., CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome. J. Clin. Invest. 129 (1): 78-92 (2019). PMID 30307408. [link to RRC of NBRP] |
---|
Featured content